RBC Capital analyst Randall Stanicky said shares of INSYS Therapeutics (NASDAQ: INSY) are over reacting to today's Linden Care news.Stanicky ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE